No photo of Elizabeth Anne Goatman

Elizabeth Anne Goatman

Dr

    • AB25 2ZD

    • 36 Citations
    20152018
    If you made any changes in Pure these will be visible here soon.

    Fingerprint Dive into the research topics where Elizabeth Anne Goatman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

    • 25 Similar Profiles
    Transgenic Mice Medicine & Life Sciences
    Synucleins Medicine & Life Sciences
    Tauopathies Medicine & Life Sciences
    Methylene Blue Medicine & Life Sciences
    Licensure Medicine & Life Sciences
    Brain Medicine & Life Sciences
    Learning Medicine & Life Sciences
    Entorhinal Cortex Medicine & Life Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output 2015 2018

    1 Citation (Scopus)
    11 Downloads (Pure)
    Open Access
    File
    Synucleins
    Transgenic Mice
    Proteins
    Parkinson Disease
    Endopeptidase K

    LMTM DECREASES α-SYNUCLEIN PATHOLOGY AND REDUCES BEHAVIOURAL DEFECTS IN α-SYNUCLEIN TRANSGENIC MICE

    Schwab, K., Frahm, S., Magbagbeolu, M., A. Goatman, E., R. Harrington, C., M. Wischik, C. & Theuring, F., 1 Jul 2017, In : Alzheimer's and Dementia. 13, 7 Suppl., p. P945-P945 1 p., P3-041.

    Research output: Contribution to journalAbstract

    35 Citations (Scopus)
    9 Downloads (Pure)

    Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models

    Melis, V., Magbagbeolu, M., Rickard, J. E., Horsley, D., Davidson, K., Harrington, K. A., Goatman, K., Goatman, E. A., Deiana, S., Close, S. P., Zabke, C., Stamer, K., Dietze, S., Schwab, K., Storey, J. M. D., Harrington, C. R., Wischik, C. M., Theuring, F. & Riedel, G., Jun 2015, In : Behavioural Pharmacology. 26, 4, p. 353-368 16 p.

    Research output: Contribution to journalArticle

    Open Access
    File
    Tauopathies
    Methylene Blue
    Transgenic Mice
    Licensure
    Brain

    Phenothiazine compounds for treating mild cognitive impairment

    Wischik, C. M., Harbaran, D. V., Riedel, G., Deiana, S., Goatman, E. A., Wischik, D. J., Murray, A. D. & Staff, R. T., 15 Dec 2015, Patent No. US9211294, 17 Jun 2008, Priority date 19 Jun 2007, Priority No. 60/945006

    Research output: Patent

    Cognitive Dysfunction
    phenothiazine